We are live on ! Find out more
ACA

Aptus Capital Advisors Portfolio holdings

AUM $12.7B
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+2.49%
1 Year Est. Return
+17.41%
3 Year Est. Return
+53.41%
5 Year Est. Return
+57.81%
10 Year Est. Return
AUM
$5.68B
AUM Growth
+$304M
Cap. Flow
+$187M
Cap. Flow %
3.29%
Top 10 Hldgs %
28.5%
Holding
1,247
New
80
Increased
530
Reduced
355
Closed
84

Sector Composition

Rank Sector Weight
1 Technology 11.47%
2 Financials 5.17%
3 Healthcare 4.4%
4 Consumer Discretionary 4.2%
5 Industrials 4.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGK icon
701
Vanguard FTSE Europe ETF
VGK
$30.8B
$230K ﹤0.01%
3,441
+63
+2% +$4.27K
SCHP icon
702
Schwab US TIPS ETF
SCHP
$16.4B
$228K ﹤0.01%
8,780
+926
+12% +$23.9K
VHT icon
703
Vanguard Health Care ETF
VHT
$18.3B
$228K ﹤0.01%
858
-4,573
-84% -$1.2M
EL icon
704
Estee Lauder
EL
$30.7B
$228K ﹤0.01%
2,144
+127
+6% +$16.7K
CTVA icon
705
Corteva
CTVA
$59.8B
$227K ﹤0.01%
4,200
+338
+9% +$18.6K
XAR icon
706
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.88B
$226K ﹤0.01%
1,615
-438
-21% -$61.1K
DEO icon
707
Diageo
DEO
$49.5B
$225K ﹤0.01%
1,786
-1,050
-37% -$145K
THQ
708
abrdn Healthcare Opportunities Fund
THQ
$781M
$225K ﹤0.01%
+11,048
New +$220K
LCTD icon
709
iShares World ex U.S. Carbon Transition Readiness Aware Active ETF
LCTD
$289M
$225K ﹤0.01%
5,023
+4
+0.1% +$182
PCG icon
710
PG&E
PCG
$39.2B
$225K ﹤0.01%
12,865
+1,771
+16% +$31.2K
IP icon
711
International Paper
IP
$22.8B
$224K ﹤0.01%
5,187
-2,864
-36% -$116K
AWK icon
712
American Water Works
AWK
$26.7B
$223K ﹤0.01%
+1,724
New +$218K
IR icon
713
Ingersoll Rand
IR
$33B
$223K ﹤0.01%
2,451
+311
+15% +$28.6K
SCHY icon
714
Schwab International Dividend Equity ETF
SCHY
$2.51B
$221K ﹤0.01%
9,378
+505
+6% +$12.2K
APAM icon
715
Artisan Partners
APAM
$2.82B
$221K ﹤0.01%
5,349
+21
+0.4% +$906
JPUS
716
JPMorgan Diversified Return US Equity ETF
JPUS
$459M
$220K ﹤0.01%
2,012
ONTO icon
717
Onto Innovation
ONTO
$12.5B
$219K ﹤0.01%
997
-138
-12% -$28.5K
AGGH icon
718
Simplify Aggregate Bond ETF
AGGH
$576M
$217K ﹤0.01%
10,436
+14
+0.1% +$292
PCF
719
High Income Securities Fund
PCF
$99.2M
$214K ﹤0.01%
30,660
GSK icon
720
GSK
GSK
$104B
$213K ﹤0.01%
5,521
+646
+13% +$27.2K
FDL icon
721
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.74B
$213K ﹤0.01%
+5,603
New +$213K
MRNA icon
722
Moderna
MRNA
$23B
$211K ﹤0.01%
+1,779
New +$225K
VCIT icon
723
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
$211K ﹤0.01%
2,634
-1,643
-38% -$130K
BCI icon
724
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.96B
$210K ﹤0.01%
+10,346
New +$213K
CHTR icon
725
Charter Communications
CHTR
$16.9B
$209K ﹤0.01%
+698
New +$191K

Similar funds

Aptus Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Aptus Capital Advisors held 1,247 positions worth $5.68B, up 5.7% from $5.38B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Aptus Capital Advisors deployed $187M of net new capital in Q2 2024, opening 80 new positions and adding to 530 existing holdings. Its largest new stake was iShares US Pharmaceuticals ETF: 183,435 shares worth $12.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $18.1M trimmed.

  • Aptus Capital Advisors's largest Q2 2024 buy was iShares US Pharmaceuticals ETF: 183,435 shares worth $12.2M.
  • Aptus Capital Advisors added most to Invesco NASDAQ 100 ETF in Q2 2024, an estimated $27.6M increase.
  • Aptus Capital Advisors's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $18.1M.
  • Aptus Capital Advisors fully exited Crocs in Q2 2024, selling an estimated $4.27M.
  • Aptus Capital Advisors's ten largest holdings make up 29% of its $5.68B portfolio in Q2 2024.
  • Aptus Capital Advisors opened 80 new positions and closed 84 in Q2 2024.
  • Aptus Capital Advisors's portfolio value rose 5.7% quarter-over-quarter to $5.68B.

Based on Aptus Capital Advisors's 13F filing for Q2 2024, filed 31 Jul 2024.